Retrospective Analysis of Treatment and Complications of Immune Checkpoint Inhibitor-Associated Colitis: Histological Ulcerations as Potential Predictor for a Steroid-Refractory Disease Course

Retrospective Analysis of Treatment and Complications of Immune Checkpoint Inhibitor-Associated Colitis: Histological Ulcerations as Potential Predictor for a Steroid-Refractory Disease Course

Background/Aims: Among the severe immune-related adverse events (irAEs) that occur with immune checkpoint inhibitor (ICI) therapy, colitis is the most frequent one. This study aimed at describing the experience from the largest gastroenterology unit in Switzerland with immune checkpoint inhibitor-as...

Full description

Bibliographic Details
Main Authors: Julian Burla, Sena Bluemel, Luc Biedermann, Marjam J. Barysch, Reinhard Dummer, Mitchell P. Levesque, Christoph Gubler, Bernhard Morell, Gerhard Rogler, Michael Scharl
Format: Article
Language:English
Published: Karger Publishers 2020-05-01
Series:Inflammatory Intestinal Diseases
Subjects:
malignant melanoma
histology
infliximab
vedolizumab
nivolumab
Online Access:https://www.karger.com/Article/FullText/507579

Internet

https://www.karger.com/Article/FullText/507579

Similar Items